Huntington's disease: How intermediate are intermediate repeat lengths?

Movement Disorders

Volumn 27, Issue 14, 2012, Pages 1714-1717

  Squitieri, Ferdinando ^a   Jankovic, Joseph ^b  

^a IRCCS NEUROMED   (Italy)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

CAG repeats; Genetic counseling; Huntington's disease; Intermediate alleles

Indexed keywords

HUNTINGTIN;

ALLELE; CAG REPEAT; DISEASE COURSE; EDITORIAL; FAMILY HISTORY; GENE MUTATION; GENETIC COUNSELING; HETEROZYGOTE; HUMAN; HUNTINGTON CHOREA; PHENOTYPE; PRIORITY JOURNAL; SUICIDAL IDEATION; SUICIDE; UNIFIED HUNTINGTON DISEASE RATING SCALE;

ALLELES; HUMANS; HUNTINGTON DISEASE; MUTATION; NERVE TISSUE PROTEINS; PHENOTYPE; TRINUCLEOTIDE REPEAT EXPANSION;

EID: 84871816787     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.25172     Document Type: Editorial

References (31)

1. Pringsheim T, Wiltshire K, Day L, Dykeman J, Steeves T, Jette N. The incidence and prevalence of Huntington's disease: A systematic review and meta-analysis. Mov Disord. 2012; 27: 1083-1091.
2. Hayden MR. Huntington's chorea. In: Huntington's Chorea. Berlin/Heidelberg/New York: Springer-Verlag; 1981: 59-92.
3. Rubinsztein DC, Amos W, Leggo J, et al. Mutational bias provides a model for the evolution of Huntington's disease and predicts a general increase in disease prevalence. Nat Genet 1994; 7: 525-530.
4. Squitieri F, Andrew SE, Goldberg YP, et al. DNA haplotype analysis of Huntington disease reveals clues to the origins and mechanisms of CAG expansion and reasons for geographic variations of prevalence. Hum Mol Genet 1994; 3: 2103-2114.
5. Warby SC, Montpetit A, Hayden AR, et al. CAG expansion in the Huntington disease gene is associated with a specific and targetable predisposing haplogroup. Am J Hum Genet 2009; 84: 351-366.
6. Hendricks AE, Latourelle JC, Lunetta KL, et al. Estimating the probability of de novo HD cases from transmissions of expanded penetrant CAG alleles in the Huntington disease gene from male carriers of high normal alleles (27-35 CAG). Am J Med Genet 2009; 149A: 1375-1381.
7. Maat-Kievit A, Helderman-van den Enden P, Losekoot M, et al. Using a roster and haplotyping is useful in risk assessment for persons with intermediate and reduced penetrance alleles in Huntington disease. Am J Med Genet 2001; 105: 737-744.
8. Sequeiros J, Ramos EM, Cerqueira J, et al. Large normal and reduced penetrance alleles in Huntington disease: instability in families and frequency at the laboratory, at the clinic and in the population. Clin Genet 2010; 78: 381-387.
9. Ha AD, Jankovic J. Exploring the correlates of intermediate CAG repeats in Huntington disease. Postgrad Med 2011; 123: 116-121.
10. Huntington's Disease Collaborative Research Group. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell 1993; 72: 971-983.
11. Kenney C, Powell S, Jankovic J. Autopsy-proven Huntington's disease with 29 trinucleotide repeats. Mov Disord 2007; 22: 127-130.
12. Herishanu YO, Parvari R, Pollack Y, et al. Huntington disease in subjects from an Israeli Karaite community carrying alleles of intermediate and expanded CAG repeats in the HTT gene: Huntington disease or phenocopy? J Neurol Sci 2009; 277: 143-146.
13. Andrich J, Arning L, Wieczorek S, Kraus PH, Gold R, Saft C. Huntington's disease as caused by 34 CAG repeats. Mov Disord 2008; 23: 879-881.
14. Groen JL, de Bie RM, Foncke EM, Roos RA, Leenders KL, Tijssen MA. Late-onset Huntington disease with intermediate CAG repeats: true or false? J Neurol Neurosurg Psychiatry 2010; 81: 228-230.
15. Squitieri F, Esmaeilzadeh M, Ciarmiello A, Jankovic J. Caudate glucose hypometabolism in a subject carrying an unstable allele of intermediate CAG33 repeat length in the Huntington's disease gene. Mov Disord 2011; 26: 925-927.
16. ACMG/ASHG statement. Laboratory guidelines for Huntington disease genetic testing. The American College of Medical Genetics/American Society of Human Genetics Huntington Disease Genetic Testing Working Group. Am J Hum Genet 1998; 62: 1243-1247.
17. Rubinsztein DC, Leggo J, Coles R, et al. Phenotypic characterization of individuals with 30-40 CAG repeats in the Huntington disease (HD) gene reveals HD cases with 36 repeats and apparently normal elderly individuals with 36-39 repeats. Am J Hum Genet 1996; 59: 16-22.
18. Squitieri F, Sabbadini G, Mandich P, et al. Family and molecular data for a fine analysis of age at onset in Huntington disease. Am J Med Genet 2000a; 95: 366-373.
19. Wexler NS, Lorimer J, Porter J, et al. Venezuelan kindreds reveal that genetic and environmental factors modulate Huntington's disease age of onset. Proc Natl Acad Sci U S A 2004; 101: 3498-3503.
20. Li XJ, Friedman M, Li S. Interacting proteins as genetic modifiers of Huntington disease. Trends Genet 2007; 23: 531-533.
21. Quarrell OW, Rigby AS, Barron L, et al. Reduced penetrance alleles for Huntington's disease: a multi-centre direct observational study. J Med Genet 2007; 44: e68.
22. Biglan KM, Jankovic J, Eberly S, et al. Longitudinal analysis of intermediate CAGn Repeat Length Expansion in the Prospective Huntington Disease At-Risk Observational Study (PHAROS) [abstract]. Mov Disord 2010; 25(Suppl 2): S183.
23. Dorsey ER; the Huntington Study Group COHORT Investigators. Characterization of a large group of individuals with Huntington disease and their relatives enrolled in the COHORT study. PLoS One 2012; 7: e29522.
24. Schöls L, Bauer P, Schmidt T, Schulte T, Riess O. Autosomal dominant cerebellar ataxias: clinical features, genetics, and pathogenesis. Lancet Neurol 2004; 3: 291-304.
25. Oda M, Maruyama H, Komure O, et al. Possible reduced penetrance of expansion of 44 to 47 CAG/CAA repeats in the TATA-binding protein gene in spinocerebellar ataxia type 17. Arch Neurol 2004; 61: 209-212.
26. Kurohara K, Kuroda Y, Maruyama H, et al. Homozygosity for an allele carrying intermediate CAG repeats in the dentatorubral-pallidoluysian atrophy (DRPLA) gene results in spastic paraplegia. Neurology 1997; 48: 1087-1090.
27. Mangiarini L, Sathasivam K, Mahal A, Mott R, Seller M, Bates GP. Instability of highly expanded CAG repeats in mice transgenic for the Huntington's disease mutation. Nat Genet 1997; 15: 197-200.
28. Gonitel R, Moffitt H, Sathasivam K, et al. DNA instability in postmitotic neurons. Proc Natl Acad Sci U S A 2008; 105: 3467-3472.
29. Swami M, Hendricks AE, Gillis T, et al. Somatic expansion of the Huntington's disease CAG repeat in the brain is associated with an earlier age of disease onset. Hum Mol Genet 2009; 15;18: 3039-3047.
30. Brocklebank D, Gayán J, Andresen JM, et al. Repeat instability in the 27-39 CAG range of the HD gene in the Venezuelan kindreds: counseling implications. Am J Med Genet B Neuropsychiatr Genet 2009; 150B: 425-429.
31. Semaka A, Creighton S, Warby S, Hayden MR. Predictive testing for Huntington disease: interpretation and significance of intermediate alleles. Clin Genet 2006; 70: 283-294.